ALEXANDRIA, Va., Aug. 16, 2011 /PRNewswire/ -- Oxford Finance LLC ("Oxford"), a specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced that it closed a $20 million senior secured term loan with Keystone Dental, Inc. Proceeds of the loan were used to pay off an existing line of credit and fund growth and working capital.
"Keystone Dental is a company with innovative products and a management team that has a great deal of experience in the dental industry," said Christopher A. Herr, managing director for Oxford Finance LLC. "Oxford is extremely pleased to provide financial support for Keystone Dental's continuing growth and the expansion of its product line."
"We are excited about our new relationship with Oxford and look forward to working with its team as we continue to expand our business," said Mark Beucler, senior vice president and chief financial officer of Keystone Dental. "Oxford provided a proposal that was superior to our incumbent bank and closed our growth loan at a record pace."
About Oxford Finance LLC
Oxford Finance is a specialty finance firm providing senior secured loans to public and private life sciences and healthcare services companies worldwide. For over 20 years, Oxford has delivered flexible financing solutions to its clients, enabling these companies to maximize their equity by leveraging their assets. In recent years, Oxford has originated over $1.5 billion in loans, with lines of credit ranging from $500 thousand to $50 million. Oxford is headquartered in Alexandria, Virginia, with additional offices in California, Illinois, Massachusetts and North Carolina. For more information visit www.oxfordfinance.com.
About Keystone Dental, Inc.
Keystone Dental is an oral healthcare company dedicated to the delivery of breakthrough technology. Keystone Dental's product portfolio includes Genesis, The Biomimetic Implant System™, The Prima™ Implant System, DynaMatrix® Extracellular Membrane, DynaBlast® and DynaGraft® bone graft substitutes, and Accell Connexus™, a next-generation bioactive bone grafting product. Founded in 2006, Keystone Dental's vision is to be a trusted oral healthcare partner focused on breakthrough technologies, whose goal is to inspire customers, instill pride in its employees, and deliver value every day. For more information visit www.keystonedental.com.
SOURCE Oxford Finance LLC